National Institute on Drug Abuse; Notice of Closed Meeting, 55375-55376 [2018-24100]

Download as PDF 55375 Federal Register / Vol. 83, No. 214 / Monday, November 5, 2018 / Notices other than their time. The total estimated annualized burden hours are 13,297. ESTIMATED ANNUALIZED BURDEN HOURS Number of respondents Type of respondent Number of responses per respondent Average time/ response (hours) Total annual burden hours High School Scientific Training & Enrichment Program—Orientation ............. High School Scientific Training & Enrichment Program 2.0—Orientation ...... HiSTEP & HiSTEP2—Alumni Tracking ........................................................... Summer Internship Program—Application ...................................................... Summer Internship Program—Recommendation Letters ................................ Amgen Scholars at NIH—Supplemental Application ....................................... Amgen Scholars at NIH—Feedback ................................................................ Amgen Scholars at NIH—Alumni Tracking ..................................................... Community College Summer Enrichment Program—Alumni Tracking ........... College—Summer Opportunities in Advanced Research—Alumni Tracking .. Graduate—Summer Opportunities in Advanced Research—Alumni Tracking Graduate Data Science Summer Program—Alumni Tracking ........................ Native American Visit Week—Application ....................................................... Native American Visit Week—Recommendation Letters ................................ Native American Visit Week—Feedback ......................................................... Undergraduate Scholarship Program—Application ......................................... Undergraduate Scholarship Program—Recommendation Letters for Applicants ............................................................................................................. Undergraduate Scholarship Program—Exceptional Financial Need—Completed by Applicant ....................................................................................... Undergraduate Scholarship Program—Exceptional Financial Need—Completed by University Staff ............................................................................. Undergraduate Scholarship Program—Exceptional Financial Need Resubmission—Completed by Applicant ............................................................... Undergraduate Scholarship Program—Exceptional Financial Need Resubmission—Completed by University Staff ...................................................... Undergraduate Scholarship Program—Scholar Contract ................................ Undergraduate Scholarship Program—Evaluation of Scholar Pay Back Period ............................................................................................................... Undergraduate Scholarship Program—Renewal Application .......................... Undergraduate Scholarship Program—Recommendation Letters for Renewals ................................................................................................................. Undergraduate Scholarship Program—Deferment Form—Completed by Scholar ......................................................................................................... Undergraduate Scholarship Program—Deferment Form—Completed by University Staff .................................................................................................. Postbaccalaureate Training Program—Application ......................................... Postbaccalaureate Training Program—Recommendation Letters .................. NIH Academy—Fellow & Certificate Programs Application ............................ NIH Academy—Enrichment Program Application ........................................... Graduate Partnerships Program—Application ................................................. Graduate Partnerships Program—Recommendation Letters for Application .. Graduate Partnerships Program—Interview Experience Survey .................... Graduate Partnerships Program—Registration ............................................... Graduate Partnerships Program—Awards Certificate ..................................... MyOITE—User Accounts ................................................................................. MyOITE—NIH Alumni ...................................................................................... OITE Careers Blog—Success Stories ............................................................. 25 25 125 8,000 16,000 535 20 127 158 158 114 30 15 15 15 125 1 1 2 1 1 1 1 1 1 1 1 1 1 1 1 1 10/60 10/60 30/60 45/60 10/60 10/60 15/60 30/60 10/60 10/60 30/60 30/60 20/60 10/60 15/60 60/60 4 4 125 6,000 2,667 89 5 64 26 26 57 15 5 3 4 125 375 1 10/60 63 125 1 3/60 8 125 1 15/60 41 38 1 3/60 8 38 25 1 1 15/60 10/60 41 4 30 15 1 1 15/60 45/60 8 11 15 1 10/60 3 10 1 3/60 1 10 2,250 6,750 300 175 325 975 30 175 75 6,000 500 6 1 1 1 1 1 1 1 1 1 1 1 1 1 12/60 45/60 10/60 15/60 15/60 60/60 10/60 10/60 15/60 30/60 3/60 15/60 45/60 2 1,688 1,125 75 44 325 163 5 44 38 300 125 5 Totals ........................................................................................................ 43,854 43,979 N/A 13,297 Dated: October 29, 2018. Lawrence A. Tabak, Deputy Director, National Institutes of Health. [FR Doc. 2018–24150 Filed 11–2–18; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute on Drug Abuse; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting. VerDate Sep<11>2014 18:38 Nov 02, 2018 Jkt 247001 PO 00000 Frm 00030 Fmt 4703 Sfmt 4703 The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The contract proposals and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the contract proposals, the disclosure of which E:\FR\FM\05NON1.SGM 05NON1 55376 Federal Register / Vol. 83, No. 214 / Monday, November 5, 2018 / Notices would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute on Drug Abuse Special Emphasis Panel; Quantification of Drugs of Abuse and Related Compounds in Biological Specimens (8951). Date: December 6, 2018. Time: 11:00 a.m. to 1:00 p.m. Agenda: To review and evaluate contract proposals. Place: National Institutes of Health, Neuroscience Center, 6001 Executive Boulevard, Rockville, MD 20852 (Telephone Conference Call). Contact Person: Lyle Furr, Scientific Review Officer, Office of Extramural Affairs, National Institute on Drug Abuse, NIH, DHHS, Room 4227, MSC 9550, 6001 Executive Boulevard, Bethesda, MD 20892– 9550, (301) 827–5702, lf33c.nih.gov. (Catalogue of Federal Domestic Assistance Program No.: 93.279, Drug Abuse and Addiction Research Programs, National Institutes of Health, HHS) Dated: October 30, 2018. Natasha M. Copeland, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2018–24100 Filed 11–2–18; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Diabetes and Digestive and Kidney Diseases Special Emphasis Panel; NIDDK SEP: RC2. Date: November 19, 2018. Time: 2:00 p.m. to 3:30 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Two Democracy Plaza, 6707 Democracy Boulevard, Bethesda, MD 20892 (Telephone Conference Call) Contact Person: Peter J. Kozel, Ph.D., Scientific Review Officer, Review Branch, DEA, NIDDK, National Institutes of Health, VerDate Sep<11>2014 18:38 Nov 02, 2018 Jkt 247001 Room 7009, 6707 Democracy Boulevard, Bethesda, MD 20892–5452, 301–594–4721, Kozelp@niddk.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.847, Diabetes, Endocrinology and Metabolic Research; 93.848, Digestive Diseases and Nutrition Research; 93.849, Kidney Diseases, Urology and Hematology Research, National Institutes of Health, HHS) Dated: October 30, 2018. David D. Clary, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2018–24098 Filed 11–2–18; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Office of the Director, National Institutes of Health; Notice of Meeting Pursuant to section 10(a) of the Federal Advisory Committee Act, as amended, notice is hereby given of a meeting of the Advisory Committee to the Director, National Institutes of Health. The meeting will be open to the public, with attendance limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting. Name of Committee: Advisory Committee to the Director, National Institutes of Health. Date: December 13, 2018. Time: 8:30 a.m. to 5:30 p.m. Agenda: NIH Director’s Report, ACD Working Group Reports, Other Business of the Committee. Place: National Institutes of Health. Building 31, 6th Floor Conference Room 6C, 31 Center Drive, Bethesda, MD 20892. Contact Person: Gretchen Wood, Staff Assistant, National Institutes of Health, Office of the Director, One Center Drive, Building 1, Room 126, Bethesda, MD 20892, 301–496–4272, Woodgs@od.nih.gov. Name of Committee: Advisory Committee to the Director, National Institutes of Health. Date: December 14, 2018. Time: 9:00 a.m. to 12:30 p.m. Agenda: ACD Working Group Reports, Other Business of the Committee. Place: National Institutes of Health, Building 31, 6th Floor Conference Room 6C, 31 Center Drive, Bethesda, MD 20892. Contact Person: Gretchen Wood, Staff Assistant, National Institutes of Health, Office of the Director, One Center Drive, Building 1, Room 126, Bethesda, MD 20892, 301–496–4272, Woodgs@od.nih.gov. Any interested person may file written comments with the committee by forwarding the statement to the Contact Person listed on PO 00000 Frm 00031 Fmt 4703 Sfmt 4703 this notice. The statement should include the name, address, telephone number and when applicable, the business or professional affiliation of the interested person. In the interest of security, NIH has instituted stringent procedures for entrance onto the NIH campus. All visitor vehicles, including taxicabs, hotel and airport shuttles will be inspected before being allowed on campus. Visitors will be asked to show one form of identification (for example, a government-issued photo ID, driver’s license, or passport) and to state the purpose of their visit. Information is also available on the Institute’s/Center’s home page: http:// acd.od.nih.gov, where an agenda and any additional information for the meeting will be posted when available. (Catalogue of Federal Domestic Assistance Program Nos. 93.14, Intramural Research Training Award; 93.22, Clinical Research Loan Repayment Program for Individuals from Disadvantaged Backgrounds; 93.232, Loan Repayment Program for Research Generally; 93.39, Academic Research Enhancement Award; 93.936, NIH Acquired Immunodeficiency Syndrome Research Loan Repayment Program; 93.187, Undergraduate Scholarship Program for Individuals from Disadvantaged Backgrounds, National Institutes of Health, HHS) Dated: October 30, 2018. Natasha M. Copeland, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2018–24097 Filed 11–2–18; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Center for Scientific Review; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Center for Scientific Review Special Emphasis Panel; Cardiovascular Disease. Date: November 13, 2018. Time: 2:00 p.m. to 4:00 p.m. Agenda: To review and evaluate grant applications. E:\FR\FM\05NON1.SGM 05NON1

Agencies

[Federal Register Volume 83, Number 214 (Monday, November 5, 2018)]
[Notices]
[Pages 55375-55376]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-24100]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute on Drug Abuse; Notice of Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The contract proposals and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the contract proposals, the disclosure of which

[[Page 55376]]

would constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute on Drug Abuse Special 
Emphasis Panel; Quantification of Drugs of Abuse and Related 
Compounds in Biological Specimens (8951).
    Date: December 6, 2018.
    Time: 11:00 a.m. to 1:00 p.m.
    Agenda: To review and evaluate contract proposals.
    Place: National Institutes of Health, Neuroscience Center, 6001 
Executive Boulevard, Rockville, MD 20852 (Telephone Conference 
Call).
    Contact Person: Lyle Furr, Scientific Review Officer, Office of 
Extramural Affairs, National Institute on Drug Abuse, NIH, DHHS, 
Room 4227, MSC 9550, 6001 Executive Boulevard, Bethesda, MD 20892-
9550, (301) 827-5702, lf33c.nih.gov.

(Catalogue of Federal Domestic Assistance Program No.: 93.279, Drug 
Abuse and Addiction Research Programs, National Institutes of 
Health, HHS)

    Dated: October 30, 2018.
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2018-24100 Filed 11-2-18; 8:45 am]
BILLING CODE 4140-01-P